|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dhanasekaran R, Limaye A and Cabrera R:
Hepatocellular carcinoma: Current trends in worldwide epidemiology,
risk factors, diagnosis, and therapeutics. Hepat Med. 4:19–37.
2012.PubMed/NCBI
|
|
3
|
Wang CH, Wey KC, Mo LR, Chang KK, Lin RC
and Kuo JJ: Current trends and recent advances in diagnosis,
therapy, and prevention of hepatocellular carcinoma. Asian Pac J
Cancer Prev. 16:3595–3604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arslanoglu A, Seyal AR, Sodagari F, Sahin
A, Miller FH, Salem R and Yaghmai V: Current guidelines for the
diagnosis and management of hepatocellular carcinoma: A comparative
review. AJR Am J Roentgenol. 207:W88–W98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Y, Jing W, Ma W, Liang C, Chai H and
Tu J: Down-regulation of long non-coding RNA GAS5-AS1 and its
prognostic and diagnostic significance in hepatocellular carcinoma.
Cancer Biomark. 2018. View Article : Google Scholar
|
|
6
|
Tateishi R, Yoshida H, Matsuyama Y, Mine
N, Kondo Y and Omata M: Diagnostic accuracy of tumor markers for
hepatocellular carcinoma: A systematic review. Hepatol Int.
2:17–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferenci P, Fried M, Labrecque D, Bruix J,
Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA,
et al: World gastroenterology organisation guideline.
Hepatocellular carcinoma (HCC): A global perspective. J
Gastrointestin Liver Dis. 19:311–317. 2010.PubMed/NCBI
|
|
8
|
Earl TM and Chapman WC: Conventional
surgical treatment of hepatocellular carcinoma. Clin Liver Dis.
15(353–370): vii–x. 2011.
|
|
9
|
Li L, Lei Q, Zhang S, Kong L and Qin B:
Screening and identification of key biomarkers in hepatocellular
carcinoma: Evidence from bioinformatic analysis. Oncol Rep.
38:2607–2618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Isin M and Dalay N: LncRNAs and neoplasia.
Clin Chim Acta. 444:280–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He T, Zhang L, Kong Y, Huang Y, Zhang Y,
Zhou D, Zhou X, Yan Y, Zhang L, Lu S, et al: Long non-coding RNA
CASC15 is upregulated in hepatocellular carcinoma and facilitates
hepatocarcinogenesis. Int J Oncol. 51:1722–1730. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J
and Liu WC: Serum long noncoding RNA urothelial
carcinoma-associated 1: A novel biomarker for diagnosis and
prognosis of hepatocellular carcinoma. J Int Med Res. 46:348–356.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sui J, Yang X, Qi W, Guo K, Gao Z, Wang L
and Sun D: Long non-coding RNA linc-USP16 functions as a tumour
suppressor in hepatocellular carcinoma by regulating PTEN
expression. Cell Physiol Biochem. 44:1188–1198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hao QQ, Chen GY, Zhang JH, Sheng JH and
Gao Y: Diagnostic value of long noncoding RNAs for hepatocellular
carcinoma: A PRISMA-compliant meta-analysis. Medicine (Baltimore).
96:e74962017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J,
Jin Y, Zheng X, Wu Y and Fu H: The long noncoding RNA expression
profile of hepatocellular carcinoma identified by microarray
analysis. PloS One. 9:e1017072014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang J, Jiang R, Deng L, Zhang X, Wang K
and Sun B: Circulation long non-coding RNAs act as biomarkers for
predicting tumorigenesis and metastasis in hepatocellular
carcinoma. Oncotarget. 6:4505–4515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui H, Zhang Y, Zhang Q, Chen W, Zhao H
and Liang J: A comprehensive genome-wide analysis of long noncoding
RNA expression profile in hepatocellular carcinoma. Cancer Med.
6:2932–2941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You J, Fang N, Gu J, Zhang Y, Li X, Zu L
and Zhou Q: Noncoding RNA small nucleolar RNA host gene 1 promote
cell proliferation in nonsmall cell lung cancer. Indian J Cancer. 3
Suppl 51:e99–e102. 2014. View Article : Google Scholar
|
|
21
|
Yu F, Bracken CP, Pillman KA, Lawrence DM,
Goodall GJ, Callen DF and Neilsen PM: p53 Represses the oncogenic
sno-MiR-28 derived from a snoRNA. PloS One. 10:e01291902015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding
F, Li D and Yang T: Long noncoding RNA SNHG1 predicts a poor
prognosis and promotes hepatocellular carcinoma tumorigenesis.
Biomed Pharmacother. 80:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Xing LQ and Liu YJ: A three-long
noncoding RNA signature as a diagnostic biomarker for
differentiating between triple-negative and non-triple-negative
breast cancers. Medicine (Baltimore). 96:e62222017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Page RD: TreeView: An application to
display phylogenetic trees on personal computers. Comput Appl
Biosci. 12:357–358. 1996.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chaiteerakij R, Addissie BD and Roberts
LR: Update on biomarkers of hepatocellular carcinoma. Clin
Gastroenterol Hepatol. 13:237–245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benson AB III, Abrams TA, Ben-Josef E,
Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica
MI, Davila R, et al: NCCN clinical practice guidelines in oncology:
Hepatobiliary cancers. J Natl Compr Canc Netw. 7:350–391. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kong FY, Xu BY, Du Y, Xu JJ and Chen HY: A
branched electrode based electrochemical platform: Towards new
label-free and reagentless simultaneous detection of two
biomarkers. Chem Commun (Camb). 49:1052–1054. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma X, Wang X, Yang C, Wang Z, Han B, Wu L
and Zhuang L: DANCR acts as a diagnostic biomarker and promotes
tumor growth and metastasis in hepatocellular carcinoma. Anticancer
Res. 36:6389–6398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jing W, Gao S, Zhu M, Luo P, Jing X, Chai
H and Tu J: Potential diagnostic value of lncRNA SPRY4-IT1 in
hepatocellular carcinoma. Oncol Rep. 36:1085–1092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan W, Sun Y, Liu L, Zhou B, Wang S and
Gu D: Circulating LncRNAs serve as diagnostic markers for
hepatocellular carcinoma. Cell Physiol Biochem. 44:125–132. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang H, Zhou D, Ying M, Chen M, Chen P,
Chen Z and Zhang F: Expression of long non-coding RNA (lncRNA)
small nucleolar RNA host gene 1 (SNHG1) exacerbates hepatocellular
carcinoma through suppressing miR-195. Med Sci Monit. 22:4820–4829.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang SL, Liu LP, Yang S, Liu L, Ren JW,
Fang X, Chen GG and Lai PB: Preoperative serum α-fetoprotein and
prognosis after hepatectomy for hepatocellular carcinoma. Br J
Surg. 103:716–724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sahu D, Hsu CL, Lin CC, Yang TW, Hsu WM,
Ho SY, Juan HF and Huang HC: Co-expression analysis identifies long
noncoding RNA SNHG1 as a novel predictor for event-free survival in
neuroblastoma. Oncotarget. 7:58022–58037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI
|
|
36
|
Zhang Y, Jin X, Wang Z, Zhang X, Liu S and
Liu G: Downregulation of SNHG1 suppresses cell proliferation and
invasion by regulating notch signaling pathway in esophageal
squamous cell cancer. Cancer Biomark. 21:89–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
